Evidence map›Paper›PMID 41176278›Full record

ReviewThe Journal of nutrition2025

Dietary and Lifestyle Risk Factors in Primary Sclerosing Cholangitis: In Search of Mechanistic Explanations and Health Improvement.

Ruslan A Mammadov, Henk P Roest, Luc Jw van der Laan, Maikel P Peppelenbosch

Abstract readReview
In one paragraph

Review in The Journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruslan A MammadovDepartment of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Henk P RoestDepartment of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Luc Jw van der LaanDepartment of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Maikel P PeppelenboschDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: m.peppelenbosch@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary sclerosing cholangitis (PSC) is a chronic, immune-mediated liver disease characterized by progressive inflammation and fibrosis of the bile ducts. Although much of the research has focused on genetic and autoimmune mechanisms, growing interest has emerged in the role of modifiable risk factors, including dietary and lifestyle factors, in the pathogenesis and progression of PSC. This review aims to provide a comprehensive synthesis of the current literature on dietary and lifestyle influences on PSC, with particular attention to underlying molecular pathways. Key factors discussed include smoking, alcohol consumption, physical activity, and medical history factors such as appendectomy, tonsillectomy, and hormonal therapies. Additionally, the review explores the impact of dietary components, such as coffee, vitamins, probiotics, and dietary fibers, on PSC progression. Potential mechanisms highlighted include alterations in bile acid metabolism, gut microbiota dysbiosis, disruption of intestinal barrier integrity, and modulation of innate and adaptive immune responses through cytokine signaling and pattern recognition receptor pathways. Emerging evidence also suggests that coffee constituents may influence oxidative stress pathways and fibrogenesis, whereas dietary fibers and probiotics may act through short-chain fatty acid production and anti-inflammatory signaling. Although the evidence for many of these factors remains inconclusive, these molecular insights point to diet-induced immunometabolism modulation as a promising area for therapeutic intervention. Further prospective studies and randomized trials are needed to clarify these mechanisms and develop targeted strategies to modify disease onset and progression.

Indexed as

Cholangitis, SclerosingDietLife StyleCoffeeExerciseGastrointestinal MicrobiomeHumansRisk FactorsCoffeebile acid metabolismdietary interventionsgut microbiotaimmune modulationprimary sclerosing cholangitisshort-chain fatty acids

Identifiers

PMID41176278
PMCPMC12799452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.